相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
Alison Cheung et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors The ALIENOR/ENGOT-ov7 Randomized Clinical Trial
Isabelle Ray-Coquard et al.
JAMA ONCOLOGY (2020)
FOXL2C134W-Induced CYP19 Expression via Cooperation With SMAD3 in HGrC1 Cells
Martina Belli et al.
ENDOCRINOLOGY (2018)
Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects
Stergios Boussios et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study*
Elizabeth R. Burton et al.
GYNECOLOGIC ONCOLOGY (2016)
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Charles J. Ryan et al.
LANCET ONCOLOGY (2015)
Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors
Jubilee Brown et al.
CANCER (2014)
Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network
Denis Maillet et al.
GYNECOLOGIC ONCOLOGY (2014)
Molecular analysis of non-epithelial ovarian cancer by histologic subtype.
Maise Al Bakir et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary
G. Mangili et al.
BRITISH JOURNAL OF CANCER (2013)
Adult granulosa cell tumours (GCT): Clinicopathological outcomes including FOXL2 mutational status and expression
Roseanne Rosario et al.
GYNECOLOGIC ONCOLOGY (2013)
Cytochrome P17 Inhibition With Ketoconazole As Treatment for Advanced Granulosa Cell Ovarian Tumor
Jesus Garcia-Donas et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary
Stacey Jamieson et al.
MODERN PATHOLOGY (2010)
FOXL2 Interacts with Steroidogenic Factor-1 (SF-1) and Represses SF-1-Induced CYP17 Transcription in Granulosa Cells
Mira Park et al.
MOLECULAR ENDOCRINOLOGY (2010)
Aromatase Is a Direct Target of FOXL2: C134W in Granulosa Cell Tumors via a Single Highly Conserved Binding Site in the Ovarian Specific Promoter
Nicholas I. Fleming et al.
PLOS ONE (2010)
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Sohrab P. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Specificity of the FOXL2 c.402C>G Somatic Mutation: A Survey of Solid Tumors
Kasmintan A. Schrader et al.
PLOS ONE (2009)
Advances in the treatment of localized prostate cancer: The role of anatomic and functional imaging in men managed with radiotherapy
Joycelyn L. Speight et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature
RD Hardy et al.
GYNECOLOGIC ONCOLOGY (2005)
Granulosa cell tumor of the ovary
ST Schumer et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)